ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer

Paolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi et al. · 2010

Read ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer by Paolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010547.txt.

Description

Paolo Kunderfranco and colleagues showed that ETS family factors switch on a silencing enzyme in prostate cancer in PLOS ONE in 2010. ETS factors guide cell growth and identity in many tissues. They have emerged as key actors in prostate tumors, though their impact was debated. The team traced one path of that impact. It runs through EZH2, an enzyme that chemically silences genes.

Under ETS control, EZH2 silenced a tumor suppressor gene called Nkx3.1. Losing that suppressor frees tumor growth. A chain from factor to enzyme to silenced guard is a satisfying mechanism. It also offers drug points along the chain, including EZH2 itself. The study helps settle what ETS factors really do in this cancer.

Catalog record

CREATORPaolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010547

Browse the full library · About the Tower of Babel